1.48Open1.50Pre Close30 Volume2.59K Open Interest5.00Strike Price4.44KTurnover160.64%IV8.33%PremiumDec 20, 2024Expiry Date1.16Intrinsic Value100Multiplier28DDays to Expiry0.32Extrinsic Value100Contract SizeAmericanOptions Type-0.6411Delta0.2187Gamma2.52Leverage Ratio-0.0110Theta-0.0026Rho-1.61Eff Leverage0.0040Vega
Revance Therapeutics Stock Discussion
📊⚡️📊
📊⚡️📊
On October 24, 2024, Revance Therapeutics, Inc. (the “Company”) and Teoxane SA (“Teoxane”), entered into the Sixth Amendment to the Exclusive Distribution Agreement (the “Sixth Amendment”). As previously disclosed on a Current Report on Form 8-K filed on January 10, 2020, the Company entered into the Exclusive Distribution Agreement with Teoxane on January 10, 2020 (the “Distribution Agreement”), pursuant to which Teoxane granted the Company with the exclus...
🟢 Recently Announced:
⇒ $Organon & Co (OGN.US)$ to acquire Dermavant
⇒ $Rafael Holdings (RFL.US)$ to acquire Cyclo Tx
⇒Crown Lab to acquire $Revance Therapeutics (RVNC.US)$
⇒ $Recursion Pharmaceuticals (RXRX.US)$ merger with Exscientia
🔴 Recently Closed:
⇒ $Johnson & Johnson (JNJ.US)$ acquired V-Wave
⇒ Pharmacosmos acquired $GTHX
What companies will be next? 🤔
No comment yet